China’s Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies

Sheng Yao, co-founder and senior vice president of Shanghai Junshi Biosciences Co., talks about the company’s agreement with Eli Lilly & Co. to co-develop therapeutic antibodies for the potential …
( read original story …)